Caribou Biosciences (CRBU) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-0.32 and quarterly revenue of $2.30M.
In the most recent quarter (Q1), Caribou Biosciences reported EPS of $-0.26, beating estimates of $-0.31 by 0.16%. Revenue came in at $2.40M, exceeding the estimate of $2.25M by 0.07%.
Caribou Biosciences has beaten EPS estimates in 8 consecutive quarters.
Over the last 4 quarters, Caribou Biosciences has averaged an EPS surprise of 0.15% and a revenue surprise of 0.31%.
Analyze the earnings history of Caribou Biosciences using advanced sorting and filters.
The chart below shows Caribou Biosciences's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Caribou Biosciences's reported revenue compared to analyst estimates over recent quarters.
Caribou Biosciences (CRBU) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
The Actual EPS was $-0.26, which beat the estimate of $-0.31.
The Actual Revenue was $2.40M, which beat the estimate of $2.25M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-07 | $-0.26 | $-0.31 | 16.1 % |
| Q4 | 2026-03-05 | $-0.28 | $-0.32 | 12.5 % |
| Q3 | 2025-11-12 | $-0.30 | $-0.36 | 16.7 % |
| Q2 | 2025-08-12 | $-0.35 | $-0.41 | 14.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-07 | $2.40M | $2.25M | 6.77 % |
| Q4 | 2026-03-05 | $3.94M | $2.19M | 80.3 % |
| Q3 | 2025-11-12 | $2.20M | $2.14M | 2.60 % |
| Q2 | 2025-08-12 | $2.67M | $1.98M | 34.6 % |